Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q3 2021 · 10-Q
Revenue$7.32M$7.32M+15.8% vs Q3 2020 Net Income-$52.99K-$52.99KN/M vs Q3 2020 EPS Diluted-$0.02-$0.02N/M vs Q3 2020 Operating Income$736,678−25.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,060,456N/M Margins · derivedOperating margin10.1%−5.6 pt vs Q3 2020
Net margin-0.7%−8.1 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end